Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3627640

Documents

In Collections

This item can be found in the following collections:

Reijers, I.L.M.; Rozeman, E.A.; Mallo, H.; Uyterlinde, W.; Adriaansz, S.; Lijnsvelt, J.; ... ; Blank, C.U. (2018)

Switch to checkpoint inhibition (CPI) after targeted therapy (TT) at time of progression or during ongoing response: A retrospective analysis of patients with advanced BRAF mutated melanoma

Article / Letter to editor
All authors
Reijers, I.L.M.; Rozeman, E.A.; Mallo, H.; Uyterlinde, W.; Adriaansz, S.; Lijnsvelt, J.; Wilgenhof, S.; Thienen, J.V. van; Haanen, J.B.A.G.; Blank, C.U.
Date
2018-10-31
Journal
Annals of Oncology
Volume
29
Pages
449 - 449